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In this study, polymeric microneedle patches were fabricated by stereolithography, a 3D 
printing technique, for the transdermal delivery of insulin. A biocompatible resin was 
photopolymerized to build pyramid and cone microneedle designs followed by inkjet print 
coating of insulin formulations., trehalose and xylitol were used as drug carriers with the aim 
to preserve insulin integrity and stability but also facilitate rapid release rates.  Circular 
dichroism and Raman analysis demonstrated that all carriers maintained the native form of 
insulin with xylitol presenting the best performance. Franz cell release studies were used for in 
vitro determination of insulin release rates in porcine skin.  Insulin was released rapidly within 
30 min irrespectively of the microneedle design. 3D printing was proved an effective 
technology for the fabrication of biocompatible and scalable microneedle patches. 
 





Over the last 20 years transdermal microneedles (MNs) have paved the way for the delivery 
of various active substances across the skin (Alkilani et al., 2015; Sanjay et al., 2017). These 
miniature devices are used for the administration of active drug substances and vaccines, 
including genetic material such as RNA and DNA (Chen et al., 2016).  MNs can pierce the skin 
in a painless way and through the penetration of the stratum corneum the drug substance is 
released  into the dermis. The minimally invasive administration of MNs has shown to improve 
systemic drug adsorption and thus bioavailability (Wermeling et al., 2008). Ideally, they 
provide improved patient compliance as they do not stimulate nerves associated with pain and 
can be self-administrated (Kaushik et al., 2001). MNs are classified into four categories 
including solid, coated, hollow, hydrogel - forming and dissolvable microneedles usually made 
of metal, polysaccharides or polymeric materials (Ita, 2015). 
Recent advances in skin delivery mediated by MNs involve the development of 
polyvinylpyrrolidone (PVP) and trehalose dissolvable MNs for the encapsulation of peptides.  
The MNs achieved rapid systemic delivery by dissolving in the interstitial fluid of the skin and 
retained the antimicrobial activity of the peptide (Dillon et al., 2017). In another study, MNs  
made of chitosan and beta-sodium glycerophosphate showed efficient delivery of 
levonorgestrel in vivo without causing any skin irritation. The pharmacokinetic profile of the 
drug, presented similarities with the respective one of oral suspension, demonstrating that drug-
loaded dissolving MN systems are an appealing alternative to traditional levonorgestrel 
administration routes (Yao et al., 2017). In another study, MNs ZHUHFRDWHGZLWKȝJRID
plasmid DNA cocktail encoding the Leishmania infantum nucleosomal histones H2A, H2B, 
H3 and H4 and their immunization capacity was compared against subcutaneous or intradermal 
injection of the plasmid. The results demonstrated that MNs improved immunogenicity, but 
higher plasmid doses might be required for better Leishmania control (Moreno et al., 2017).  
Significant efforts have been made in the skin delivery of insulin analogs by using MNs in 
order to address the accuracy of the injections, decrease leakage of insulin to the skin surface, 
and reduce pain caused by repeated injections (Guo and Wang, 2017; Narayan, 2014). In a 
recent study, MNs for insulin delivery, composed of modified alginate and hyaluronate, were 
fabricated by micromoulding (Yu et al., 2017). The optimized MNs showed good mechanical 
strength and piercing capacity while insulin bioactivity was not affected.  In vivo studies 
demonstrated a sustained hypoglycaemic effect with high relative pharmacologic availability 
and relative bioavailability, compared to subcutaneous injections. Clinical studies in diabetic 
Sprague ± Dawley rats demonstrated effective hypoglycaemic control when insulin was 
released from calcium sulfate and gelatine biodegradable composite microneedle patches, 




However, there are several pitfalls in MN skin delivery related to the manufacturing process 
and materials used for the development of MN patches. Micromoulding is the most common 
approach used for the fabrication of dissolving and gel forming MNs and involves a sequence 
of time-consuming and difficult to scale-up steps.  On the other hand, coating technologies do 
not always result in uniform, accurate and reproducible active coated layers and fail to avoid 
drug deposition on the MNs substrate. There are also serious concerns regarding the 
biocompatibility, skin irritation and even sterilization issues (McCrudden et al., 2015) of the 
materials (e.g. silicon, polymers) used for MNs fabrication as most of them are suitable for oral 
use but not approved for skin delivery. The limited loading of active substances in most of 
these MN technologies is another shortcoming for efficient transdermal delivery. More 
explicitly, coating techniques limit the drug amount that can be loaded in the system to 1 mg 
maximum (Kim et al., 2012) while larger amounts (up to 33 mg) have been successfully 
delivered by dissolving MN (McCrudden et al., 2014). 
3D printing or additive manufacturing is a family of technologies that employ a virtual 
Computer Aided Design (CAD) model to create a physical object through the consecutive 
creation of layers. It was launched in 1980s (Kodama, 1981; Hull, 1984) and it has 
revolutionized the field of pharmaceutical, biomedical and material sciences due to the 
capabilities for rapid and cost-effective prototyping of complex structures (Pedde et al., 
2017).3D printing endows the prototyping and fabrication process with versatility; objects are 
manufactured in a one-step fashion with high degrees of complexity and reproducibility. .  
Among the various technologies that comprise 3D printing, photopolymerisation-based 
techniques enable the fabrication of structures through the consecutive layer-wise 
polymerization of UV-sensitive polymers, through a curing process named 
photopolymerization. Stereolithography (SLA), Digital Light Processing (DLP) and Two-
Photon-Polymerization (2PP) are among these technologies (Economidou et al., 2018). In the 
field of Transdermal Drug Delivery (TDD), Gittard et al. employed a photopolymerisation-
based printer (DLP) to fabricate MNs of various geometries for wound healing applications 
followed by pulse laser deposition of silver and zinc oxide thin films (Gittard et al., 2011). 
Similarly, Lu et al. incorporated Dacarbazine (1-2%), a skin anticancer drug, into 
poly(propylene fumarate)/drug blends followed by photopolymerization through a micro-
stereolithographic (DLP)apparatus that built the MN arrays (Lu et al., 2015). 
In this study, we employed SLA to fabricate MN arrays of different designs followed by 
inkjet printing of insulin ± polysaccharide films. 3D printed patches, featuring MN with cone 
and pyramid geometries, were made using a Class 1 biocompatible resin with excellent 
mechanical strength and piercing capacity. Mannitol, trehalose and xylitol, were used as insulin 
carriers at different wt/wt ratios in order to preserve insulin activity prior to the application of 
XQLIRUPDQGDFFXUDWH³DFWLYH´FRDWLQJRQWKH01VXUIDFH 
 
2. Materials and Methods 
Insulin solution from bovine pancreas (10 mg mL-1) and trehalose dihydrate were 
purchased from Sigma-Aldrich (Gillingham, UK), while Xylisorb£ 90 (Xylitol) and 
Pearlitol£ (mannitol) were kindly donated by Roquette Freres (France). The printing polymer 
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was the biocompatible Class I resin, Dental SG, procured by Formlabs. All solvents were of 
analytical grades.  
 
2.1 3D printing of microneedles 
Two different MN designs, pyramid and cone, were developed using appropriate 
engineering software (SolidWorks by Dassault Systems), featuring square and circular cross-
sections, respectively. The length of all MNs was 1 mm while the dimensions of the base cross-
sections were 1x1 mm for the pyramid and ø 1 mm for the cone. The MNs were built as attached 
to a solid 15x15x1 mm substrate, forming patches of 48 MNs each. The arrays were fabricated 
using a Form 2 stereolithography (SLA) printer by Formlabs, with high resolution capabilities 
(25 and 140 microns for z and x axes, respectively). To obtain higher mechanical properties, 
the MN arrays, after being washed in isopropyl alcohol to remove excess resin, were cured 
under ultraviolet radiation for 60 min at 40oC (MeccatroniCore BB Cure Dental station). 
 
 
2.2 Inkjet printing of insulin formulations microneedles 
The insulin solutions were printed onto each MN surface in the form of fine droplets using 
an inkjet printer (NanoPlotter II, Gesim, Germany) through a piezo-driven dispenser (PicPip 
300). All MN arrays were positioned at 45º relative to the dispenser and for each coating cycle, 
10 dots of 2 droplets of a coating formulation were dispensed longitudinally to the axis of each 
MN. The process was repeated for 92 jetting cycles resulting in 10 UI (350 µg) of insulin per 
array. Solvent (de-ionised water) was evaporated to produce uniform and reproducible solid 
thin films on the MNs after 24 h of incubation at room temperature.  For the purposes of this 
study three coating formulations were used, consisting of insulin:xylitol (5:1 wt/wt), insulin: 
mannitol (5:1 wt/wt) and insulin:trehalose (5:1 wt/wt) as 2% solid content.  
 
2.3 Scanning electron microscopy (SEM) 
The coated MN arrays were mounted onto aluminium stubs using a double-sided carbon 
adhesive tape (Agar scientific, UK). Each coated cross-MN array was examined by SEM 
(Hitachi SU 8030, Japan) using a low accelerating voltage (1.0kV). A low accelerating voltage 
was used to avoid electrical charges on the cross-MNs. The images of coated cross-MNs were 
captured digitally from a fixed working distance (11.6 mm) using different magnifications (30, 
80, 110 or 120 x).  
 
2.4 Circular Dicroism (CD) analysis 
The formulations were diluted to 1.0 mg mL-1 in deionized water and the spectra were recorded 
at 20 ºC between 190 and 260 nm by CD (Chirascan, Applied Photophysics, UK) using a 0.1 
mm polarization certified quartz cell (Hellma). Spectra were recorded using a step size of 1 
nm, a bandwidth of 1 nm and an acquisition time of 1 sec. Four scans were recorded for each 
sample, averaged and a corresponding spectrum of water was subtracted from each spectrum. 
For estimation of the secondary structural composition of insulin, the CD spectra were 




2.5 Raman analysis 
The films of the formulations and their respective components were analysed using Raman 
microscopy (Jobin Yvon LabRam I) with a laser of 532 nm wavelength coupled with an optical 
microscope with 50x objective. 
 
2.6  Penetration of MN in porcine skin 
The necessary force required to pierce the skin has been found to be straightforwardly affected 
by the geometry of the MNs (Davis et al., 2004). In this study, to determine the effect of needle 
shape on the force required for skin penetration, piercing tests using porcine skin were 
conducted. In order to have a frame of reference with respective literature, metallic MN arrays 
were tested as well, the fabrication and physical characteristics of which, are described 
elsewhere (Ross et al., 2015). A texture analyser was employed, and the MN array was mounted 
on the moving probe using double-sided adhesive tape. Prior to testing, the porcine skin 
samples were placed in waxed petri dishes. Continuous force and displacement measurements 
were recorded to identify the point of needle insertion. The speed of the moving probe was 
0.01 mm/s. 
 
2.7 In vitro release of insulin coated MNs 
Release studies of insulin were undertaken in abdominal porcine skin using Franz diffusion 
cells (PermeGear, Inc., PA, USA). Full thickness abdominal porcine skin was collected from a 
local slaughterhouse (Forge Farm Ltd, Kent, UK). The abdominal hair was shaved using a razor 
blade. Collected skin was stored at 4ºC until it was used. A total diffusion area of 1.1 cm2 was 
used to assess insulin release into abdominal porcine skin. Skin (750 µm thick) was cut for 
permeability studies of insulin using a dermatome instrument (Padgett dermatome or blade, 
USA). Skin samples were then placed in phosphate buffered saline (PBS; pH 7.4) for 1 h before 
the in vitro studies. The MN arrays were inserted into abdominal porcine skin (900 µm) for 30 
s using manual finger pressure. A skin pierced cross-MN array was mounted onto the donor 
compartment of a Franz diffusion cell. The temperature of the Franz cells was maintained at 
37ºC using an automated water bath (Thermo Fisher Scientific, Newington, USA) whilst the 
skin temperature was maintained at 32ºC using a digital thermometer (Fisher Scientific, UK). 
Sample fractions (6-6.5 mL/h) were collected using an auto-sampler (FC 204 fraction collector, 
Gilson, USA) attached to the Franz diffusion cells. Statistical analysis for the drug release was 
SHUIRUPHGE\XVLQJD0DQQí:KLWQH\QRQSDUDPHWULF WHVW DQG W-test analysis for the in vivo 
studies (InStat, GraphPad Software Inc., San Diego, CA, USA), where samples are considered 
to be statistically significant at p < 0.05. 
 
2.9 Skin preparation for in-vitro MN testing 
The fatty tissue below the abdominal area of porcine skin was removed with scalpel and then 
pinned onto polystyrene block and wiped with 70 % ethanol. The skin was then cut at 1 mm 
by applying the dermatome at an angle of ±45° (Padgett dermatome, Integra LifeTMSciences 
Corporation USA). The thickness of the skin was measured by using a calliper and the tissue 
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disks of the required dimensions were cut for the Franz diffusion cells using a scalper. The skin 
tissue (1.0±0.1 mm thick) was placed onto filter paper soaked in a small amount of saline 
phosphate buffer (pH 7.4) for 2 h. 
 
2.10 HPLC analysis 
The amount of insulin collected from the receptor fluid was determined by High-Performance 
Liquid Chromatography (HPLC; Agilent Technologies, 1200 series, Cheshire, UK) equipped 
ZLWK D3KHQRPHQH[-XSLWHUXFc /&&ROXPQ îPPSDUWLFOH VL]HȝP
Macclesfield, UK). The mobile phase consisted of water with 0.1 % TFA and acetonitrile with 
0.1% TFA (66:34v/v), with a 1 mL miní1 flow rate. The column was equilibrated at 35°C, the 
LQMHFWLRQYROXPHZDVȝ/DQGWKHHOXHQWZDVDQDO\VHGZLWKD89GHWHFWRUDWQP7KH
results were integrated using Chemstation® software and the samples analysed in triplicates. 
 
 
3. Results and discussion 
MN arrays with cone- and pyramid- shaped needles were successfully printed using an 
additive manufacturing technique known as stereolithography. The SLA processes a Class I 
biocompatible resin to build up structures in a layer ± by ± layer manner from computer aided 
design (CAD) models. Dental SG resin is one of the few commercially available, 
biocompatible, FDA certified polymers that are compatible with stereolithography printers and 
the only Class I compatible with the Form2 system. After printing, the MN arrays were cured 
using a light source ± UV laser to harden the plastic MN patches through a photopolymerization 
process resulting in improved mechanical properties. As shown in Fig. 1 SLA produced two 
different designs of pyramid (6x8) and cone±shaped (6x8) MN patches with 1000 Pm height, 
1000 Pm width and 1.85 mm interspacing distance (measured from tip-to-tip). In Fig. 1c&d 
the build layers of both MN designs appear highly consistent and reproducible. The high 
resolution of the printer permitted the reproducible fabrication of arrays in excellent detail, 
leading to the formation of sharp needle tips that favour the skin insertion. The low cost of the 
printing material and the fast production speed renders SLA an attractive process for MN 
fabrication. Quantitively, the currently available commercial SLA apparatuses have a limited 
print volume and the existing print volume (145 × 145 × 175 mm ) allows the manufacturing 
of up to 49 MN arrays within 2h according to the dimensions and methodology described. 
Upscaling of the process at a manufacturing scale depends on the introduction of printers with 
larger print volumes. However, considering the low cost of these printers and the short 
fabrication time, parallel printings in multiple printers can generate a great number of arrays 





Fig. 1: SEM images of 3D printed microneedle designs of:  a) plain pyramid, b) plain cone, c) 
insulin coated pyramid and c) insulin coated cone. 
 
Inkjet printing was then employed to apply coatings of insulin and sugar alcohol solutions 
through a piezoelectric dispenser. This 2D printing approach has been previously used for 
coating of metal MNs(Ross et al., 2015; Uddin et al., 2015) where by optimizing the applied 
voltage (mV) and the pulse duration (ms) droplets of 300 pL volume with consistent particle 
size of 100 ± 110 PPDVREVHUYHGE\WKHSULQWHU¶VVWURERVFRSH, were produced. 7KHGLVSHQVHU¶V
tip (50Pm) was kept close to the microneedle surface to avoid losses of the coating material. 
Fig. 2 shows the morphologically excellent coatings on the MN surface without the presence 
of any satellite droplets on the substrate. In addition, the inkjet printing led to the formation of 
uniform layers with high precision and reproducibility without the creation of bulky coatings 
observed in conventional techniques such as dip coating.   
The coating formulations consisted of insulin solutions of two alcohol sugars (xylitol, 
mannitol) and disaccharide (trehalose) specifically selected as drug carries. The selection of 
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those excipients was twofold, firstly because they favour and enhance insulin stability in solid 
state and secondly we anticipated a rapid coating dissolution immediately after the MN piercing 














Fig. 2:  Inkjet coating process of 3D printed microneedles. 
 
Circular Dichroism 
Circular dichroism (CD) is a well-known spectroscopic technique used to study the 
secondary structure of proteins and polypeptides in solution. In order to investigate the effect 
of different sugars on the structure of insulin, CD experiments were carried out. The secondary 
structure of insulin in all samples was also estimated by the CDSSTR method (Sreerama and 
Woody, 2000) and it is quantitatively summarized in Table 1. 
In Fig. 3 all far-UV CD spectra of insulin and insulin-sugar formulations showed two 
negative minima around 210 and 225 nm commonly associated with predominant features of 
Į-helices structure which is in close agreement with the spectra already reported in the literature 
(Ettinger and Timasheff, 1971; Sarmento et al., 2007; Yong et al., 2009; Andrade et al., 2015). 
Also, the secondary structure of pure insulin in solution estimated by CDSSTR method, agree 
well with that obtained by others (Melberg and Johnson 1990; Yong et al. 2009). The spectra 
of insulin-mannitol and insulin-trehalose show a slightly decrease in the absolute intensities at 
 DQG  QP ZKLFK FDQ LQGLFDWH FKDQJHV LQ WKH UDWLR RI Į-KHOL[ DQG ȕ-sheet content. 
$FFRUGLQJWRWKHVHFRQGDU\VWUXFWXUHHVWLPDWLRQWKHVHFKDQJHVGRLQGLFDWHDGHFUHDVHLQĮ-helix 
content of 4 and 5% for mannitol and trehalose formulations, respectively, with a 
VLPXOWDQHRXVO\LQFUHDVHRILQWKHȕ-VKHHW$OWKRXJKVLPLODUHIIHFWRIWUHKDORVHRQĮ-helix 
content was reported by Yong et al. (Yong et al., 2009), the reason for this is still unclear and 
further research is needed. 
Among the tested sugars, xylitol presented the best capability to maintain insulin in its native 
IRUP ZLWK DOPRVW WKH VDPH DPRXQW RI Į-helix content. Regarding the stability and storage 
requirements insulin coated MN arrays where placed for stability studies at 2 -  8°C for 30 
days. The stored samples were further examined by CD and no changes on the spectra where 
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observed compare to the freshly coated MNs (data not shown). These findings suggest that 
coating formulations provide efficient insulin protection according to regulatory requirements. 
 
 
Fig. 3:  CD of insulin and insulin formulations. 
Table 1: Secondary structure prediction by CDSSTR using far-ultraviolet CD spectra. 
  





Alpha Helix 58% 57% 54% 53% 
ȕ-Sheet 7% 7% 10% 10% 
Turn 10% 11% 11% 11% 
Random coil 26% 26% 26% 26% 
 
Raman spectroscopy 
Raman spectroscopy has been widely used to study possible changes in chemical 
composition as well to study important information about protein conformation. 
In this study, the spectrum of native insulin, Fig. 4, shows a strong amide I band at 1661 
cm-1 and a shoulder near 1682 cm-1 (CO stretching with some contribution from the stretching 
of CN groups and CCN deformations) ZKLFKDUHLQGLFDWLYHRIĮ-helix structure and random 
coil form, respectively, being in accordance with Yu et al. (Yu et al., 1972).  
All insulin formulations spectra display a similar band shape to the native insulin, 
DVVLJQLQJ WKH Į-helix structure. However, insulin-xylitol and insulin-mannitol formulation 
display a shift toward greater frequency, 1663 cm-1 and 1662 cm-1, respectively, and insulin-
trehalose was shifted to lower frequency at 1658 cm-1. Furthermore, for mannitol formulation, 
an increase the amide I peak absorbance was seen while a pronounced decrease was noted for 
trehalose one. Those changes might be due to the different effect of each sugar on the 






























adjacent peptide units as stated by Carpenter and Crowe (Carpenter and Crowe, 1989) and 
Souillac et al. (Souillac et al., 2002). 
Characteristic peaks of sugars were not found in Raman spectra due to the fact that 
insulin is more concentrated in the formulations films compared to the carbohydrate films and 
X-ray diffraction (XRD) analysis (data not shown) suggested that the sugars were amorphous 
and therefore is likely to afford a weak Raman spectrum. It has also been suggested that there 
is also hydrogen bond between the sugar and the dried protein as reported by Carpenter and 
Crowe (Carpenter and Crowe, 1989). This interaction is known as water-replacement 
mechanism and it is responsible for preventing protein denaturation by replacing water 
molecules with other hydrogen bond reducing then the probability of protein aggregation 
during the drying process (Souillac et al., 2002). Therefore, the developed formulations have 
JRRGFDSDELOLW\WRPDLQWDLQLQVXOLQPROHFXOHLQLWVQDWLYHIRUPZLWKKLJKDPRXQWVRIĮ-helix 
content which is essential for its biological activity. 
 
Fig.4:  Raman spectra from 400 to 1800 cm-1 of pure insulin and insulin formulations. 
 
Penetration of MN in porcine skin  
The polymeric arrays featuring different MN shapes along with the metallic ones were 
inserted in porcine skin samples using a texture analyser. All MN designs successfully pierced 
the skin and no MN failure was reported. Force against displacement data were continuously 
recorded throughout the penetration and the data are shown in Fig. 5. 


















Fig. 5: Force vs displacement curves for MN penetration in porcine skin. 
The sharp drop of the load corresponds to the insertion of the MN into the skin (Davis et al., 
2004). Prior to that event, all curves present an initial linear portion (displacement < 0.3 mm). 
The slope then change constantly as the MN continues to penetrate the skin revealing a non-
linear connection between the developed forces and the penetration depth.  
 
Fig. 6: Maximum forces for MN penetration in porcine skin. 
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This behaviour could be attributed to the viscoelastic nature of the skin tissue, however 
indentation studies by Pailler-Mattei et al. (Pailler-Mattei et al., 2008) proposed the neglecting 
of the viscous part and the consideration of the skin as an elastic material in the load range of 
0-20 N. Considering that all the measurements are well below the 20 N margin, a linear 
connection between force and displacement throughout the test should be expected. The 
divergence from linearity shows that the needle penetration of the skin starts earlier than the 
sharp drop of load. The load increases as the needle goes deeper through the skin until a 
threshold force is reached and insertion becomes abrupt. These findings are in accordance with 
the work from Gittard et al. (Gittard et al., 2013) that concluded that MN penetration should be 
viewed as a series of sequential penetrations until a maximum force is applied, rather than a 
single event. The threshold load indicates that the MN insertion is successful, and the respective 
values are depicted in Fig. 6.  
Regarding the different designs and apart from the metallic MN that require the 
maximum threshold force for penetration, the cone design requires the least force to penetrate 
the porcine skin. Since both designs are dimensionally similar, the variation of the maximum 
load required for penetration can be attributed to the difference of the MN-to-skin contact area 
between the two designs. Indeed, Equation (1) yields a total contact surface for the cone design, 
of 1.76 mm2 per needle. On the other hand, the lateral surface for pyramid is found to be 2.24 
mm2 per needle, from Equation (2).  ܵ௖௢௡௘ ൌ ߨݎ ?݄ ଶ ൅ ݎଶ                Eq. (1) 
where: r is the base radius and h the height of the MN. ܵ௣௬௥௔௠௜ௗ ൌ ݈ට௪ଶ ଶ ൅ ݄ଶ ൅ ݓට௟ଶଶ ൅ ݄ଶ             Eq. (2) 
where: l is the length of the base, w the width of the base, and h the height of the MN.  
 
The 21% difference in area between the two designs indicates that the frictional forces 
after initial penetration until the threshold force in reached, and are greater for the pyramid 
needles. As a result, greater loads are required to achieve further penetration through the skin. 
 
Insulin release studies 
In vitro insulin release studies were conducted using dermatomed porcine skin through 
Franz diffusion cells.  The alcohol sugars (mannitol, xylitol) and the disaccharide sugar 
(trehalose) provided excellent coatings on the MN surface and due to their hydrophilic nature 
were expected to provide rapid release rates. Indeed, as shown in Fig 7a&b the observed insulin 
release rates in the first 2 min varied from 63 to 69% and from 57 to 64% for the pyramid and 
cone ±shaped 3D microneedles, respectively. After 20 min more than 80% of insulin was 
detected LQ WKH UHFHSWRU¶VFRPSDUWPHQWDQG± 95% in 30 min.  Furthermore, the release 
profiles were almost identical for all carries and no statistical difference was observed for each 
MN design (two-tail p = 0.0026). The rapid insulin profiles were attributed to the extremely 
high hydration rates of the alcohol sugars and the disaccharide respectively in the porcine skin 





Fig. 7: Dissolution profiles of insulin 3D printed cone and pyramid shaped microneedles. 
 
4. Conclusions 
A 3D printing stereolithographic technique was introduced for the fabrication of 
microneedle designs for insulin transdermal delivery.  SLA facilitated the printing of high 
quality MNs with various designs.  Insulin formulations with mannitol, trehalose and xylitol 
were coated on the MN surface using inkjet printing to provide accurate and reproducible active 
coating layers.  All carriers were found to preserve insulin integrity namely the Į±helix and ȕ-
Sheet with xylitol presenting the foremost performance. Franz cell diffusion studies revealed 
rapid insulin release rates within 30 min. In conclusion, it has been demonstrated that 3D 
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